BODI vs ARQ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

BODI

54.2
AI Score
VS
BODI Wins

ARQ

35.7
AI Score

Investment Advisor Scores

BODI

54score
Recommendation
HOLD

ARQ

36score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric BODI ARQ Winner
Forward P/E 25.1256 65.7895 BODI
PEG Ratio 0 11.7462 Tie
Revenue Growth -22.4% 4.5% ARQ
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 54.2/100 35.7/100 BODI
Profit Margin 5.7% -42.2% BODI
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL BODI

Relative Price Performance (Last 90 Days)

BODI 1M: -40.6% · 3M: -41.7% ARQ 1M: +12.7% · 3M: -7.3%

Current Technical Phase

BODI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.1%), weak momentum, RSI 32

RSI (14): 31.6 · Price: $6.37

ARQ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 56.6 · Price: $2.30

Fundamentals Snapshot

Metric BODI ARQ
Market Cap
Forward P/E 70.8 -32.9
Trailing P/E 3.7
Revenue (TTM)
Revenue Growth -0.2% 0.0%
Gross Margin 0.7% 0.3%
Operating Margin 0.0% 0.0%
EPS 1.76 -1.29
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BODI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.